Mar 21, 2023 / 04:00PM GMT
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst
Good afternoon. I'd like to welcome everyone to the KeyBanc Life Sciences & MedTech Investor Forum. My name is Matt Mishan. I'm our senior med tech analyst and I'm pleased to be joined by Teleflex, who is represented today by Tom Powell, Executive Vice President and CFO; as well as Larry Keusch, VP of IR and Strategy Development. For the audience, I'm going to start this off, but questions can be submitted directly to me by typing in the box below on the video screen and I can relay. Tom, Larry, thank you very much for joining us.
Questions and Answers:
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research AnalystI think my opening question is pretty straightforward. Just how would you compare the current environment and your level of visibility at the start of 2023 to what you saw over the last couple of years?
Thomas E. Powell - Teleflex Incorporated - Executive